Evelo Biosciences Inc. (EVLO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
0.32
63080.00%
After-hours Dec 11, 2023, 06:46 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 47.94M | 68.44M | 68.86M | 77.83M | 147.92M | 38.25M | 15.54M |
Short-Term Investments | n/a | n/a | n/a | n/a | 54.82M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.16M | 1.31M | 3.55M | 4.75M | 5.02M | 1.51M | 346.00K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.63M | 2.58M | 2.12M | 3.18M | 3.70M | 531.00K | 184.00K |
Total Current Assets | 51.57M | 71.03M | 68.86M | 77.83M | 147.92M | 38.78M | 15.72M |
Property-Plant & Equipment | 11.71M | 15.53M | 18.23M | 8.34M | 6.92M | 3.50M | 2.50M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.87M | 16.84M | 21.78M | 13.09M | 11.95M | 5.01M | 2.85M |
Total Assets | 64.44M | 87.87M | 90.64M | 90.92M | 159.87M | 43.79M | 18.57M |
Account Payables | 1.76M | 1.60M | 1.44M | 620.00K | 1.52M | 1.41M | 637.00K |
Deferred Revenue | n/a | 13.07M | -2.14M | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.26M | 3.90M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.37M | -7.04M | 18.39M | 9.12M | 7.72M | 2.43M | 1.61M |
Total Current Liabilities | 12.39M | 17.36M | 19.83M | 9.74M | 9.23M | 3.84M | 2.25M |
Long-Term Debt | 48.88M | 54.34M | 40.04M | 19.63M | 12.30M | 9.97M | 9.93M |
Other Long-Term Liabilities | 8.16M | n/a | 284.00K | 1.35M | 1.38M | 580.00K | 865.00K |
Total Long-Term Liabilities | 57.04M | 61.84M | 40.32M | 20.98M | 13.68M | 10.55M | 10.80M |
Total Liabilities | 69.43M | 79.20M | 60.15M | 30.72M | 22.92M | 14.38M | 13.04M |
Total Debt | 51.14M | 56.29M | 40.04M | 19.63M | 12.30M | 9.97M | 9.93M |
Common Stock | 111.00K | 54.00K | 47.00K | 32.00K | 32.00K | 20.00K | 4.00K |
Retained Earnings | -529.22M | -414.69M | -292.52M | -198.85M | -113.38M | -56.41M | -28.34M |
Comprehensive Income | n/a | n/a | n/a | -90.92M | -18.00K | -1.43M | -595.00K |
Shareholders Equity | -4.99M | 8.67M | 30.48M | 60.20M | 136.95M | 29.40M | 5.53M |
Total Investments | n/a | n/a | n/a | n/a | 54.82M | n/a | n/a |